Praram 9 Hospital Public Co Limited

Praram 9 Hospital Public Co Limited

19.00
THB
-0.30
(-1.55%)
1.03EPS
17.20P/E
13.92BMarket Cap
Nov 06Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
296.17
326.71
373.06
403.58
4.26
3.62
3.31
3.8
5.22
5.34
5.9
6.71
6.81
Basic EPS, GAAP
27.03
32.27
43.3
43.71
0.25
0.36
0.26
0.32
0.72
0.71
0.91
1.05
1.03
Free Cash Flow per Basic Share
- -
- -
9.43
-16.65
-0.53
-0.44
-0.42
0.43
0.93
0.63
1.01
0.58
0.35
Dividend per Share
- -
- -
7.87
7.86
0.77
0.14
0.14
0.11
0.14
0.3
0.45
0.45
0.5
Book Value per Share
259.7
278.23
313.48
349.17
4.93
5.14
5.23
5.44
6.02
6.46
6.92
7.47
7.64
Tangible Book Value per Share
239.59
262.3
297.09
333.9
4.82
5.04
5.1
5.33
5.92
6.36
6.82
7.32
7.45
Basic Weighted Avg Shares
6
6
6
6
635
786
786
786
786
786
786
786
786
Sales/Revenue/Turnover
1,777
1,960
2,238
2,421
2,701
2,849
2,601
2,987
4,107
4,202
4,635
5,277
5,355
Operating Margin (%)
11.44
12.65
14.19
13.09
7.46
11.44
8.19
9.49
16.48
15.35
17.13
17.95
17.43
Depreciation Expense
107
114
132
151
156
164
213
294
299
299
306
313
335
Net Income, GAAP
162
194
260
262
157
284
202
249
568
558
713
823
809
Effective Tax Rate (%)
20.26
21.95
18.17
17.29
27.11
18.17
12.26
17.02
18.92
18.99
17.32
18.8
18.21
Profit Margin (%)
9.13
9.88
11.61
10.83
5.82
9.99
7.77
8.34
13.82
13.28
15.37
15.59
15.11
Working Capital
595
650
701
224
1,600
1,120
712
936
1,414
1,620
1,900
2,482
2,537
LT Debt
- -
- -
- -
- -
- -
- -
3
2
4
3
1
9
7
Total Equity
1,558
1,669
1,881
2,095
3,873
4,039
4,115
4,278
4,735
5,080
5,439
5,876
6,008
Return on Invested Capital (%)
- -
11.93
14.57
13.16
4.92
6.92
4.85
5.89
12.5
10.92
12.76
13.84
13.34
Return on Capital (%)
- -
12
14.64
13.19
5.27
7.19
4.96
5.94
12.58
11.36
13.54
14.53
13.9
Return on Common Equity (%)
- -
12
14.64
13.19
5.27
7.19
4.96
5.94
12.59
11.37
13.55
14.54
13.91

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
7
7
7
LT Borrowings
- -
- -
- -
LT Finance Leases
9
9
7
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
786
786
786
Market Capitalization
14,704
12,974
13,918

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,363
3,567
3,413
Cash, Cash Equivalents & STI
2,682
2,807
2,727
Accounts Receivable, Net
562
644
571
Inventories
65
80
77
Total Current Liabilities
880
946
876
Payables & Accruals
791
896
821
ST Debt
7
7
7
Deferred Revenue
- -
- -
- -

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.21%
7.4%
8.04%
Free Cash Flow
- -
-19.97%
-42.04%
Net Income, GAAP
23.96%
38.52%
15.44%
Sales/Revenue/Turnover
10.95%
15.76%
13.83%
Total Cash Common Dividend
- -
33.8%
0.05%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,071
1,084
1,226
1,255
4,635
2025
1,239
1,277
1,364
1,397
5,277
2026
1,284
1,311
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.2
0.18
0.26
0.26
0.91
2025
0.25
0.23
0.28
0.28
1.05
2026
0.23
0.23
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.3
- -
0.15
0.45
2025
- -
0.25
- -
0.2
0.45
2026
- -
0.3
- -
- -
- -

Company Description

CEO
Satian Pooprasert
Full Time Employees
1,558
Sector
Health services
Industry
Hospital/Nursing management
Address
99, Rama IX Road Bangkok BM Thailand 10310
IPO Date
Oct 30, 2018
Business
Praram 9 Hospital Public Company Limited (PR9.BK) operates a multispecialty hospital in Bangkok, Thailand, providing comprehensive healthcare services to both Thai and international patients. Founded in 1992 and headquartered at 99 Rama IX Road, Bangkapi, Huai Khwang, Bangkok, the company offers outpatient and inpatient care across numerous centers and institutes, including medicine; surgery; diabetes and metabolic; spine; orthopedic; physical therapy and rehabilitation; chest and respiratory; neurology; thyroid and thyroid surgery; obstetrics gynecology; IVF; breast; oncocare; emergency; imaging; Lasik; skin and plastic surgery; mind; gastrointestinal and liver disease; dental; check-up; eye; pediatric; sleep; ear, nose, and throat; vaccination and travel medicine; and traditional Chinese medicine clinics; as well as the Praram 9 Kidney Transplantation Institute, Praram 9 Cardiovascular Institute, and pain management and wellness services. The hospital serves primarily self-pay and insurance patients, with a growing focus on international markets such as the Middle East, Laos, Cambodia, and CLMV countries, alongside Thai domestic customers. In recent developments, Praram 9 Hospital received the Collaboration Silver Award from Muang Thai Life Assurance Public Company Limited for enhanced healthcare partnerships; partnered with Cariva's (Thailand) Co., Ltd. to introduce 53-gene genetic testing for cancer risk assessment; earned SET Awards 2025 for Sustainability Excellence and Outstanding Investor Relations, Bangkok Life Hospital Awards 2025 for medical management excellence, and three IAA Awards for Listed Companies 2025; collaborated with AIS on e-waste management initiatives; and reported strong financial growth in the first half of 2024 with total revenues up 9.8% to Baht 2,178.0 million and net profit up 29.7% to Baht 298.1 million, driven by increased international and insurance patient volumes, OPD/IPD expansions, and marketing efforts targeting fly-in patients. The company continues to invest in brand awareness, facility renovations, cost management, and financial assets for higher returns while maintaining a debt-to-equity ratio of 0.2 times.